http://rdf.ncbi.nlm.nih.gov/pubchem/patent/GB-1188349-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_97a285d8ecd0184a7e5d89a1e4e07997
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D217-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D217-14
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D217-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D217-14
filingDate 1967-04-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d06d7ebaae7e4003b4b3d40275b114d4
publicationDate 1970-04-15-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber GB-1188349-A
titleOfInvention Tartranilic Acid Derivatives, their preparation and their use as Resolving Agents
abstract 1,188,349. Tartranilic acid derivatives. BRISTOL-MYERS CO. 28 April, 1967 [29 April, 1966], No. 19693/67. Heading C2C. Novel optically active tartranilic acid derivatives having the general formula wherein R<SP>1</SP> is hydrogen, chloro, bromo or nitro and R<SP>2</SP> is hydrogen, chloro or bromo, but R<SP>1</SP> and R<SP>2</SP> are not both hydrogen, and acid addition salts thereof are prepared by heating a mixture of an optically active isomer of 2,3-diacetoxy succinic anhydride or a corresponding mono-acid halide or mono-mixed anhydride and an aniline derivative of the general formula to produce a diacetyl-tartranilic acid derivative which is deacetylated by treatment with alkali. (+)-2,3-Diacetoxysuccinic anhydride is prepared by reacting (+)-tartaric acid and acetic anhydride. Racemic organic amines are resolved by (a) forming a mixture of the two enantiomeric salts of the amine with an optically active tartranilic acid derivative of the first general formula above, (b) separating said enantiomeric salts by fractional crystallization and (c) converting said separated enantiomeric salts to the respective optical isomers of the organic amine. Examples of amines which can be resolved are (Œ)-6,7- dimethoxy - 1 - # - hydroxyethyl - 2 - methyl- 1,2,3,4 - tetrahydroisoquinoline (A), (Œ) - 1- (# - p - chlorothiophenoxy - ethyl) - 6,7 - dimethoxy - 2 - methyl - 1,2,3,4 - tetrahydroisoquinoline (B) and (Œ)-6,7-dimethoxy-1,2,3,4- tetrahydroisoquinoline - 1 - acetic acid ethyl ester (C). The optical isomers of amine (A) may be reacted with p-bromobenzene sulphonyl chloride in the presence of chloroform and sodium carbonate to give the optical isomers of [2,1-a] - azetidino - 6,7 - methoxy - 2 - methyl- 1,2,3,4 - tetrahydroisoquinolium p - bromobenzenesulphonate, which may be treated with pchlorothiophenol to form the optical isomers of amine (B). Racemic amine (B) is prepared (i) by reaction of #-p-chlorothiophenoxypropionic and homoveratrylamine, treatment of the resulting # - (p - chlorothiophenoxy) - propionic homoveratrylamide with phosphoryl chloride, reduction of the 1 -(#-p-chlorothiophenoxyethyl)-6,7- dimethoxy - 3,4 - dihydroisoquinoline so produced with sodium borohydride or lithium aluminium hydride and treatment of the 1-(#-pchlorothiophenoxyethyl) - 6,7 - dimethoxy- 1,2,3,4- tetrahydroisoquinoline thus obtained with formaldehyde and formic acid; or (ii) by reaction of homoveratrylamine with diethyl ethoxymethylene-malonate, followed by treatment with hydrochloric acid and then oxalic acid, reaction of the resulting 6,7 - dimethoxy-1,2,3,4-tetrahydroisoquinoline - 1 - acetic acid ethyl ester oxalate, i.e. the oxalate of amine (C), with formaldehyde and formic acid, followed by hydrochloric acid, reduction of the free base corresponding to the 6,7-dimethoxy-2-methyl-1,2,3,4- tetrahydroisoquinoline - 1 - acetic acid ethyl ester hydrochloride so obtained with lithium aluminium hydride, reaction of the free base corresponding to the resulting 6,7-dimethoxy-1-#- hydroxyethyl - 2 - methyl - 1,2,3,4 - tetrahydroisoquinoline hydrochloride with p-bromobenzenesulphonyl chloride in the presence of chloroform and sodium carbonate and reaction of the [2,1-a] - azetidino - 6,7 - dimethoxy - 2 - methyl- 1,2,3,4 - tetrahydroisoquinolinium p - bromobenzenesulphonate thus produced with p-chlorothiophenol.
priorityDate 1966-04-29-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7396
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419558313
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6212
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID425901710
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID22959485
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID454306093
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419557048
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID414861851
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID160192269
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7815
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6871
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID452298102
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID416130518
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419474387
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID455695671
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID66545374
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID414860179
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8421
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID407631466
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID154082929
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID451404211
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458427722
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4311764
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID313
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7918
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10340
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID448098817
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID971
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID284
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID444305
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419540504
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID449271001
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419546200
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID408499458
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457192620
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID431906198
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID451732157
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID95411
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1551619
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24813
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID712
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID449445756
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID158421503
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458392451
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415796601
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID424480289
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419558780

Total number of triples: 60.